LUV-17171-68053
2 vaccinations
1 coded response
2 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 551 / MN
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-04
Dose 1 — Pfizer-BioNTech
-
2021-01-25
Dose 2 — Pfizer-BioNTech
-
2021-03-27
Registered in v-safe
-
2021-04-26
Survey response — 3 months, dose 2MedDRA: Hospitalisation, Postpartum state, Pre-eclampsia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Postpartum preeclampsia · Healthcare visit (other): Prolonged hospitalizationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-26
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-28
- 2021-12-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Pfizer-BioNTech | |
| 2 | 2021-01-25 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 8 — 3 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Hospitalisation | ✓ | ✓ | ✓ |
| SD | Postpartum state | ✓ | ✓ | ✓ |
| SD | Pre-eclampsia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release